Related references
Note: Only part of the references are listed.RPPApipe: A pipeline for the analysis of reverse-phase protein array data
Johannes Eichner et al.
BIOSYSTEMS (2014)
A pilot study utilizing multi-omic molecular profiling to find potential targets and select individualized treatments for patients with previously treated metastatic breast cancer
Gayle S. Jameson et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Glioblastoma Cell Enrichment Is Critical for Analysis of Phosphorylated Drug Targets and Proteomic-Genomic Correlations
Claudius Mueller et al.
CANCER RESEARCH (2014)
Pilot Phase I/II Personalized Therapy Trial for Metastatic Colorectal Cancer: Evaluating the Feasibility of Protein Pathway Activation Mapping for Stratifying Patients to Therapy with Imatinib and Panitumumab
M. Pierobon et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Realizing the Promise of Reverse Phase Protein Arrays for Clinical, Translational, and Basic Research: A Workshop Report
Rehan Akbani et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Bioinformatic analysis reveals a pattern of STAT3-associated gene expression specific to basal-like breast cancers in human tumors
Robert W. Tell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Proteogenomic convergence for understanding cancer pathways and networks
Emily S. Boja et al.
CLINICAL PROTEOMICS (2014)
Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution
Lalit R. Patel et al.
CANCER LETTERS (2013)
Panitumumab-FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Jean-Yves Douillard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
T. S. Gujral et al.
ONCOGENE (2013)
-Omics and Cancer Biomarkers: Link to the Biological Truth or Bear the Consequences
Lance A. Liotta et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Julia D. Wulfkuhle et al.
CLINICAL CANCER RESEARCH (2012)
Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL-CALGB 150007/150012, ACRIN 6657
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Aberrant Expression of Proteins Involved in Signal Transduction and DNA Repair Pathways in Lung Cancer and Their Association with Clinical Parameters
Yong He et al.
PLOS ONE (2012)
NormaCurve: A SuperCurve-Based Method That Simultaneously Quantifies and Normalizes Reverse Phase Protein Array Data
Sylvie Troncale et al.
PLOS ONE (2012)
One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens
Claudius Mueller et al.
PLOS ONE (2011)
What is the malignant nature of human ductal carcinoma in situ?
Virginia Espina et al.
NATURE REVIEWS CANCER (2011)
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing
Alessandra Silvestri et al.
LABORATORY INVESTIGATION (2010)
Reverse phase protein microarrays advance to use in clinical trials
Claudius Mueller et al.
MOLECULAR ONCOLOGY (2010)
Translating cancer research into targeted therapeutics
J. S. de Bono et al.
NATURE (2010)
Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for Survival
Virginia Espina et al.
PLOS ONE (2010)
Reverse-Phase Phosphoproteome Analysis of Signaling Pathways Induced by Rift Valley Fever Virus in Human Small Airway Epithelial Cells
Taissia G. Popova et al.
PLOS ONE (2010)
Combining laser capture microdissection and proteomics: Methodologies and clinical applications
Baogang J. Xu
PROTEOMICS CLINICAL APPLICATIONS (2010)
Activated VEGF Receptor Shed Into the Vitreous in Eyes With Wet AMD A New Class of Biomarkers in the Vitreous With Potential for Predicting the Treatment Timing and Monitoring Response
Geetanjali Davuluri et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
I-SPY 2: An Adaptive Breast Cancer Trial Design in the Setting of Neoadjuvant Chemotherapy
A. D. Barker et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Application of Laser Microdissection and Reverse-Phase Protein Microarrays to the Molecular Profiling of Cancer Signal Pathway Networks in the Tissue Microenvironment
Virginia Espina et al.
CLINICS IN LABORATORY MEDICINE (2009)
Tissue is alive: New technologies are needed to address the problems of protein biomarker pre-analytical variability
Virginia Espina et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Tracing pathway activities with kinase inhibitors and reverse phase protein arrays
Jan van Oostrum et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer
Rafael G. Amado et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy
Julia D. Wulfkuhle et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Laser Capture Microdissection and Protein Microarray Analysis of Human Non-small Cell Lung Cancer DIFFERENTIAL EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PHOSPHORYLATION EVENTS ASSOCIATED WITH MUTATED EGFR COMPARED WITH WILD TYPE
Amy J. VanMeter et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
A Portrait of Tissue Phosphoprotein Stability in the Clinical Tissue Procurement Process
Virginia Espina et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Signal pathway pro. ling of epithelial and stromal compartments of colonic carcinoma reveals epithelial-mesenchymal transition
K. M. Sheehan et al.
ONCOGENE (2008)
The minimum information about a proteomics experiment (MIAPE)
Chris F. Taylor et al.
NATURE BIOTECHNOLOGY (2007)
The needle in the haystack: Application of breast fine-needle aspirate samples to quantitative protein microarray technology
Amy Rapkiewicz et al.
CANCER CYTOPATHOLOGY (2007)
Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival
Emanuel F. Petricoin et al.
CANCER RESEARCH (2007)
Demands on scientific studies: Vitality of wounds and wound age estimation
Wolfgang Grellner et al.
FORENSIC SCIENCE INTERNATIONAL (2007)
Reverse-phase protein microarrays: application to biomarker discovery and translational medicine
Amy VanMeter et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2007)
Technology insight: pharmacoproteomics for cancer - promises of patient-tailored medicine using protein microarrays
Julia D. Wulfkuhle et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer
C Gulmann et al.
JOURNAL OF PATHOLOGY (2006)
Laser-capture microdissection
Virginia Espina et al.
NATURE PROTOCOLS (2006)
Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma
C Gulmann et al.
CLINICAL CANCER RESEARCH (2005)
Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis
C Belluco et al.
CLINICA CHIMICA ACTA (2005)
Mapping molecular networks using proteomics: A vision for patient-tailored combination therapy
EF Petricoin et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The time to onset and overall analgesic efficacy of rofecoxib 50 mg - A meta-analysis of 13 randomized clinical trials
PJ Desjardins et al.
CLINICAL JOURNAL OF PAIN (2005)
Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma
KM Sheehan et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Progress in protein and antibody microarray technology
P Angenendt
DRUG DISCOVERY TODAY (2005)
Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain
XH Li et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Current two-dimensional electrophoresis technology for proteomics
A Görg et al.
PROTEOMICS (2004)
Genomic and proteomic technologies for individualisation and improvement of cancer treatment
J Wulfkuhle et al.
EUROPEAN JOURNAL OF CANCER (2004)
Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control
LC Chen et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2004)
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays
S Nishizuka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Protein microarrays: Molecular profiling technologies for clinical specimens
V Espina et al.
PROTEOMICS (2003)
Protein microarrays: Meeting analytical challenges for clinical applications
LA Liotta et al.
CANCER CELL (2003)
Clinical proteomics: Translating benchside promise into bedside reality
EF Petricoin et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Clinical application of pharmacogenetics
BB Spear et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
CP Paweletz et al.
ONCOGENE (2001)
Share Paper
